164 related articles for article (PubMed ID: 37938847)
1. Generalizability and Out-of-Sample Predictive Ability of Associations Between Neuromelanin-Sensitive Magnetic Resonance Imaging and Psychosis in Antipsychotic-Free Individuals.
Wengler K; Baker SC; Velikovskaya A; Fogelson A; Girgis RR; Reyes-Madrigal F; Lee S; de la Fuente-Sandoval C; Ojeil N; Horga G
JAMA Psychiatry; 2024 Feb; 81(2):198-208. PubMed ID: 37938847
[TBL] [Abstract][Full Text] [Related]
2. Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression.
Koutsouleris N; Dwyer DB; Degenhardt F; Maj C; Urquijo-Castro MF; Sanfelici R; Popovic D; Oeztuerk O; Haas SS; Weiske J; Ruef A; Kambeitz-Ilankovic L; Antonucci LA; Neufang S; Schmidt-Kraepelin C; Ruhrmann S; Penzel N; Kambeitz J; Haidl TK; Rosen M; Chisholm K; Riecher-Rössler A; Egloff L; Schmidt A; Andreou C; Hietala J; Schirmer T; Romer G; Walger P; Franscini M; Traber-Walker N; Schimmelmann BG; Flückiger R; Michel C; Rössler W; Borisov O; Krawitz PM; Heekeren K; Buechler R; Pantelis C; Falkai P; Salokangas RKR; Lencer R; Bertolino A; Borgwardt S; Noethen M; Brambilla P; Wood SJ; Upthegrove R; Schultze-Lutter F; Theodoridou A; Meisenzahl E;
JAMA Psychiatry; 2021 Feb; 78(2):195-209. PubMed ID: 33263726
[TBL] [Abstract][Full Text] [Related]
3. Neuromelanin-Sensitive MRI as Candidate Marker for Treatment Resistance in First-Episode Schizophrenia.
van der Pluijm M; Wengler K; Reijers PN; Cassidy CM; Tjong Tjin Joe K; de Peuter OR; Horga G; Booij J; de Haan L; van de Giessen E
Am J Psychiatry; 2024 Jun; 181(6):512-519. PubMed ID: 38476044
[TBL] [Abstract][Full Text] [Related]
4. A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia.
Jauhar S; Nour MM; Veronese M; Rogdaki M; Bonoldi I; Azis M; Turkheimer F; McGuire P; Young AH; Howes OD
JAMA Psychiatry; 2017 Dec; 74(12):1206-1213. PubMed ID: 29049482
[TBL] [Abstract][Full Text] [Related]
5. Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis.
Hamilton HK; Roach BJ; Bachman PM; Belger A; Carrión RE; Duncan E; Johannesen JK; Light GA; Niznikiewicz MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Cannon TD; Mathalon DH
JAMA Psychiatry; 2022 Aug; 79(8):780-789. PubMed ID: 35675082
[TBL] [Abstract][Full Text] [Related]
6. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.
; Jalbrzikowski M; Hayes RA; Wood SJ; Nordholm D; Zhou JH; Fusar-Poli P; Uhlhaas PJ; Takahashi T; Sugranyes G; Kwak YB; Mathalon DH; Katagiri N; Hooker CI; Smigielski L; Colibazzi T; Via E; Tang J; Koike S; Rasser PE; Michel C; Lebedeva I; Hegelstad WTV; de la Fuente-Sandoval C; Waltz JA; Mizrahi R; Corcoran CM; Resch F; Tamnes CK; Haas SS; Lemmers-Jansen ILJ; Agartz I; Allen P; Amminger GP; Andreassen OA; Atkinson K; Bachman P; Baeza I; Baldwin H; Bartholomeusz CF; Borgwardt S; Catalano S; Chee MWL; Chen X; Cho KIK; Cooper RE; Cropley VL; Dolz M; Ebdrup BH; Fortea A; Glenthøj LB; Glenthøj BY; de Haan L; Hamilton HK; Harris MA; Haut KM; He Y; Heekeren K; Heinz A; Hubl D; Hwang WJ; Kaess M; Kasai K; Kim M; Kindler J; Klaunig MJ; Koppel A; Kristensen TD; Kwon JS; Lawrie SM; Lee J; León-Ortiz P; Lin A; Loewy RL; Ma X; McGorry P; McGuire P; Mizuno M; Møller P; Moncada-Habib T; Muñoz-Samons D; Nelson B; Nemoto T; Nordentoft M; Omelchenko MA; Oppedal K; Ouyang L; Pantelis C; Pariente JC; Raghava JM; Reyes-Madrigal F; Roach BJ; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Schiffman J; Schlagenhauf F; Schmidt A; Sørensen ME; Suzuki M; Theodoridou A; Tomyshev AS; Tor J; Værnes TG; Velakoulis D; Venegoni GD; Vinogradov S; Wenneberg C; Westlye LT; Yamasue H; Yuan L; Yung AR; van Amelsvoort TAMJ; Turner JA; van Erp TGM; Thompson PM; Hernaus D
JAMA Psychiatry; 2021 Jul; 78(7):753-766. PubMed ID: 33950164
[TBL] [Abstract][Full Text] [Related]
7. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain.
Cassidy CM; Zucca FA; Girgis RR; Baker SC; Weinstein JJ; Sharp ME; Bellei C; Valmadre A; Vanegas N; Kegeles LS; Brucato G; Kang UJ; Sulzer D; Zecca L; Abi-Dargham A; Horga G
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5108-5117. PubMed ID: 30796187
[TBL] [Abstract][Full Text] [Related]
8. Disorganized Gyrification Network Properties During the Transition to Psychosis.
Das T; Borgwardt S; Hauke DJ; Harrisberger F; Lang UE; Riecher-Rössler A; Palaniyappan L; Schmidt A
JAMA Psychiatry; 2018 Jun; 75(6):613-622. PubMed ID: 29710118
[TBL] [Abstract][Full Text] [Related]
9. Cross-Scanner Harmonization of Neuromelanin-Sensitive MRI for Multisite Studies.
Wengler K; Cassidy C; van der Pluijm M; Weinstein JJ; Abi-Dargham A; van de Giessen E; Horga G
J Magn Reson Imaging; 2021 Oct; 54(4):1189-1199. PubMed ID: 33960063
[TBL] [Abstract][Full Text] [Related]
10. Association of Hippocampal Atrophy With Duration of Untreated Psychosis and Molecular Biomarkers During Initial Antipsychotic Treatment of First-Episode Psychosis.
Goff DC; Zeng B; Ardekani BA; Diminich ED; Tang Y; Fan X; Galatzer-Levy I; Li C; Troxel AB; Wang J
JAMA Psychiatry; 2018 Apr; 75(4):370-378. PubMed ID: 29466532
[TBL] [Abstract][Full Text] [Related]
11. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.
Modinos G; Kempton MJ; Tognin S; Calem M; Porffy L; Antoniades M; Mason A; Azis M; Allen P; Nelson B; McGorry P; Pantelis C; Riecher-Rössler A; Borgwardt S; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Glenthøj B; Ruhrmann S; Sachs G; Rutten B; van Os J; de Haan L; Velthorst E; van der Gaag M; Valmaggia LR; McGuire P;
JAMA Psychiatry; 2020 Feb; 77(2):190-200. PubMed ID: 31722018
[TBL] [Abstract][Full Text] [Related]
12. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.
Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
JAMA Psychiatry; 2018 Sep; 75(9):960-968. PubMed ID: 29971330
[TBL] [Abstract][Full Text] [Related]
13. Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals.
Zhang T; Wang J; Xu L; Wei Y; Tang X; Hu Y; Cui H; Tang Y; Li C; Ling Z; Wang J
Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):591-602. PubMed ID: 34536114
[TBL] [Abstract][Full Text] [Related]
14. Network-Based Spreading of Gray Matter Changes Across Different Stages of Psychosis.
Chopra S; Segal A; Oldham S; Holmes A; Sabaroedin K; Orchard ER; Francey SM; O'Donoghue B; Cropley V; Nelson B; Graham J; Baldwin L; Tiego J; Yuen HP; Allott K; Alvarez-Jimenez M; Harrigan S; Fulcher BD; Aquino K; Pantelis C; Wood SJ; Bellgrove M; McGorry PD; Fornito A
JAMA Psychiatry; 2023 Dec; 80(12):1246-1257. PubMed ID: 37728918
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis.
Borgan F; Laurikainen H; Veronese M; Marques TR; Haaparanta-Solin M; Solin O; Dahoun T; Rogdaki M; Salokangas RK; Karukivi M; Di Forti M; Turkheimer F; Hietala J; Howes O;
JAMA Psychiatry; 2019 Oct; 76(10):1074-1084. PubMed ID: 31268519
[TBL] [Abstract][Full Text] [Related]
16. Clinical, Brain, and Multilevel Clustering in Early Psychosis and Affective Stages.
Dwyer DB; Buciuman MO; Ruef A; Kambeitz J; Sen Dong M; Stinson C; Kambeitz-Ilankovic L; Degenhardt F; Sanfelici R; Antonucci LA; Lalousis PA; Wenzel J; Urquijo-Castro MF; Popovic D; Oeztuerk OF; Haas SS; Weiske J; Hauke D; Neufang S; Schmidt-Kraepelin C; Ruhrmann S; Penzel N; Lichtenstein T; Rosen M; Chisholm K; Riecher-Rössler A; Egloff L; Schmidt A; Andreou C; Hietala J; Schirmer T; Romer G; Michel C; Rössler W; Maj C; Borisov O; Krawitz PM; Falkai P; Pantelis C; Lencer R; Bertolino A; Borgwardt S; Noethen M; Brambilla P; Schultze-Lutter F; Meisenzahl E; Wood SJ; Davatzikos C; Upthegrove R; Salokangas RKR; Koutsouleris N;
JAMA Psychiatry; 2022 Jul; 79(7):677-689. PubMed ID: 35583903
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic Exposure in Clinical High Risk of Psychosis: Empirical Insights From a Large Cohort Study.
Zeng J; Raballo A; Gan R; Wu G; Wei Y; Xu L; Tang X; Hu Y; Tang Y; Chen T; Li C; Wang J; Zhang T
J Clin Psychiatry; 2022 Mar; 83(3):. PubMed ID: 35324095
[No Abstract] [Full Text] [Related]
18. A Functional Connectome-Based Neural Signature for Individualized Prediction of Antipsychotic Response in First-Episode Psychosis.
Cao H; Lencz T; Gallego JA; Rubio JM; John M; Barber AD; Birnbaum ML; Robinson DG; Malhotra AK
Am J Psychiatry; 2023 Nov; 180(11):827-835. PubMed ID: 37644811
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
[TBL] [Abstract][Full Text] [Related]
20. [Minor neurological and physical anomalies in patients with first-episode psychosis].
Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
